Core Laboratories N.V. (CLB) Tops Q3 EPS by 2c; Guides Q4 Above Views
Core Laboratories N.V. (NYSE: CLB) reported Q3 EPS of $1.36, $0.02 better than the analyst estimate of $1.34. Revenue for ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
